Tuberculosis (TB)
- Use multiple active drugs—never monotherapy
- Drug-susceptible TB has 4- or 6-month options
- Classic regimen begins HRZE
- isoniazid/rifamycin/PZA/ethambutol
- 4-month HPZM regimen is an approved option
- Check susceptibilities, interactions + adherence
- Public-health follow-up is part of treatment
Use at a glance
- Use multiple active drugs—never monotherapy
Treatment options
- Drug-susceptible TB has 4- or 6-month options
Practical pearls
- Classic regimen begins HRZE
- isoniazid/rifamycin/PZA/ethambutol
- 4-month HPZM regimen is an approved option
Monitoring / follow-up
- Check susceptibilities, interactions + adherence
- Public-health follow-up is part of treatment
Self-check
- What is checked in TB treatment?
Susceptibilities, interactions + adherence. - What drug strategy treats TB?
Multiple active drugs—never monotherapy.
Drugs used for this (7)
All clinical uses · Open Tuberculosis (TB) in the interactive console ↗